Element Capital Management LLC Lipocine Inc. Transaction History

Element Capital Management LLC

  • $2.17 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2017

Feb 14, 2018
SELL
$3.36 - $4.35 $37,164 - $48,115
-11,061 Closed
0 $0
Q3 2017

Nov 13, 2017
SELL
$3.67 - $4.19 $255,740 - $291,975
-69,684 Reduced 86.3%
11,061 $44,000
Q2 2017

Aug 14, 2017
BUY
N/A
80,745
80,745 $325,000

About Lipocine Inc.

LPCN Quotes by TradingView
  • Ticker LPCN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 88,510,800
  • Market Cap $468M
  • Description
  • Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Its lead product candidate is TLANDO, an oral testosterone rep...
More about LPCN
Track This Portfolio

Track Element Capital Management LLC Portfolio

Follow Element Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Element Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Element Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email